Potential Biomarkers in Predicting Progression of Epithelial Hyperplastic Lesions of the Larynx

Acta Oto-Laryngologica

Volumn 117, Issue sup527, 1997, Pages 30-38

  Gallo, Oreste ^a   Franchi, Alessandro ^a   Chiarelli, Ilaria ^a   Porfirio, Berardino ^a   Grande, Antonio ^a   Simonetti, Laura ^a   Bocciolini, Corso ^a   Fini Storchi, Omero ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

chromosome mutagen sensitivity; laryngeal cancer; laryngeal pre cancerosis; p53 gene; proliferative activity

Indexed keywords

BIOLOGICAL MARKER; BLEOMYCIN; CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; NUCLEAR PROTEIN; TUMOR MARKER; CARCINOGEN; PROTEIN P53;

ARTICLE; BIOPSY; CASE CONTROL STUDY; CELL TRANSFORMATION; CHROMOSOME FRAGILITY; DNA SEQUENCE; EPITHELIUM; FEMALE; GENETICS; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LARYNX DISORDER; LARYNX MUCOSA; LARYNX TUMOR; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; PRECANCER; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; GENE MUTATION; HUMAN CELL; HUMAN TISSUE; KERATOSIS; LARYNX CANCER; LARYNX CARCINOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGNOSIS;

ANTIGENS, NUCLEAR; BIOLOGICAL MARKERS; BIOPSY; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME FRAGILITY; EPITHELIUM; FEMALE; GENES, P53; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LARYNGEAL DISEASES; LARYNGEAL MUCOSA; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; PRECANCEROUS CONDITIONS; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 0030629395     PISSN: 00016489     EISSN: 16512251     Source Type: Journal    
DOI: 10.3109/00016489709124030     Document Type: Article

References (25)

1. Weinsten I B. The origin of human cancer: inolecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment. Twenty-seventh G.H.A. Clowes Memorial Award Lecture. Cancer Res 1988; 48: 4135 – 43
2. Vokes E E, Weichselbauni R R, Lippman S M, Hong W K. Head and neck cancer. New Engl J Med 1993; 328: 184 – 94
3. Friedniann I. Precursor of squamous cell carcinoma. Surgical pathology of laryngeal neoplasms, A Ferlito. Chapman & Hall, London 1996; 107 – 21
4. Dolcetti R, Doglioni C, Maestro R, et al. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer 1992; 52: 178 – 82
5. Shin D M, Kiln J, Ro J Y, Hittelman J, Roth J A, Hong W K, Hittelman W N. Activation of p53 gene expression in premalignant lesions during head & neck tumorigen-esis. Cancer Res 1994; 54: 321 – 6
6. Shin D M, Voravud N, Ro J Y, Lee J S, Hong W K, Hittelman W N. Sequential increases in proliferative cell nuclear antigen expression in head and neck tumorige-nesis: a potential biomarker. J Natl Cancer Inst 1993; 85: 971 – 8
7. Zidar N, Gale N, Cör A., Kambič V. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx. J Laryngol Otol 1996; 110: 440 – 5
8. Gourgoulis V, Zoumpourlis V, Rassidakis G, et al. Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions, p53 protein immunohisto-chemical expression is positively related to proliferating cell nuclear antigen labelling index. Virchows Arch 1995; 426: 339 – 44
9. Bouquot J E. Epidemiology. Pathology of the head and neck, D R Gnepp. Churchill-Livingstone, New York 1988; 263 – 314
10. Gallo O, Bianchi S, Giannini A, Boccuzzi S, Calzolari A, Fini-Storchi O. Lack of detection of human papillo-mavirus (HPV) in transformed laryngeal keratoses by in situ hybridization (ISH) technique. Acta Otolaryngol (Stockh) 1994; 114: 213 – 7
11. Fouret P, Dabit D, Sibony M, et al. Expression of pS3 protein related to the presence of human papillo-mavirus infection in precancer lesions of the larynx. Am J Pathol 1995; 146: 599 – 604
12. Gallo O, Bianchi S, Giovannucci-Uzielli M L, et al. p53 oncoprotein overexpression correlates with mutagen-induced chromosome fragility in head and neck cancer patients with multiple malignancies. Br J Cancer 1995; 71: 1008 – 12
13. Schantz S P, Hsu T C. Mutagen-induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients. Head Neck 1989; 11: 337 – 42
14. Spitz M R, Fueger J J, Beddingfield N A, et al. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 1989; 49: 4626 – 8
15. Schantz S P, Hsu T C, Ainslie N, Moser R P. Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosome damage. JAMA 1989; 262: 3313 – 5
16. Toguchida J, Yamaguchi T, Ritchie B, et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 1992; 52: 6194 – 9
17. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 1992; 7: 927 – 33
18. Cuchi A, Boinbi J A, Avellaneda R, Cardesa A, Traserra J. Precancerous lesions of the larynx: clinical and pathologic correlations and prognostic aspects. Head Neck 1994; 16: 545 – 9
19. Parshad R, Sandford K K, Jones G M. Chromatid damage after G2 phase X-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. Proc Natl Acad Sci 1993; 80: 5612 – 6
20. Davidson B J, Hsu T C, Schantz S P. The genetics of tobacco-induced malignancy. Arch Otolaryngol Head Neck Surg 1993; 119: 1198 – 205
21. Munck-Wikland E, Edstrom S, Jungmark E, Kuyliensterna R, Lindholm J, Auer G. Nuclear DNA content, proliferating nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Int J Cancer 1994; 56: 95 – 9
22. Boyle J A, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993; 53: 4477 – 80
23. El-Naggar A K, Lai S, Luna M A, et al. Sequential p53 mutation analysis of pre-invasive and invasive head & neck squamous carcinoma. Int J Cancer 1995; 64: 196 – 201
24. Gale N, Poljak M, Kambič V, Ferluga D. Abnormal p53 expression in benign and malignant laryngeal hyperplastic lesions. Pathol Res Pract 1993; 189: 701
25. Birchall M A, Winterford C M, Allan D J, Harmon B V. Apoptosis in normal epithelium, premalignant and malignant lesions of the oropharynx and oral cavity: a preliminary study. Eur J Cancer 1995; 31B: 380 – 3